Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem.

Doern GV, Carroll KC, Diekema DJ, Garey KW, Rupp ME, Weinstein MP, Sexton DJ.

Clin Microbiol Rev. 2019 Oct 30;33(1). pii: e00009-19. doi: 10.1128/CMR.00009-19. Print 2019 Dec 18. Review.

PMID:
31666280
2.

Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013.

Richter SS, Doern GV, Heilmann KP, Miner S, Tendolkar S, Riahi F, Diekema DJ.

J Clin Microbiol. 2016 Mar;54(3):812-4. doi: 10.1128/JCM.03109-15. Epub 2016 Jan 13.

3.

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.

Antimicrob Agents Chemother. 2014 Nov;58(11):6484-9. doi: 10.1128/AAC.03344-14. Epub 2014 Aug 18.

4.

The value of outcomes data in the practice of clinical microbiology.

Doern GV.

J Clin Microbiol. 2014 May;52(5):1314-6. doi: 10.1128/JCM.00712-14. Epub 2014 Mar 12. No abstract available.

5.

Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study.

Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, McDanel JS, Doern GV.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):285-92. doi: 10.1086/675283. Epub 2014 Jan 29.

PMID:
24521595
6.

Biographical feature: Silas G. Farmer, Ph.D.

Doern GV.

J Clin Microbiol. 2014 Feb;52(2):384-6. doi: 10.1128/JCM.03130-13. Epub 2013 Dec 4. No abstract available.

7.

Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Crispell EK, Riahi F, McDanel JS, Satola SW, Doern GV.

Antimicrob Agents Chemother. 2014;58(2):740-5. doi: 10.1128/AAC.01915-13. Epub 2013 Nov 18.

8.

Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

J Clin Microbiol. 2013 Dec;51(12):4193-5. doi: 10.1128/JCM.01876-13. Epub 2013 Sep 11.

9.

Antimicrobial stewardship programs.

Leuthner KD, Doern GV.

J Clin Microbiol. 2013 Dec;51(12):3916-20. doi: 10.1128/JCM.01751-13. Epub 2013 Aug 7. Review.

10.

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

Emerg Infect Dis. 2013 Jul;19(7):1074-83. doi: 10.3201/eid1907.121830.

11.

Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Winokur PL, Chaloner K, Doern GV, Ferreira J, Apicella MA.

J Infect Dis. 2013 Sep 1;208(5):728-38. doi: 10.1093/infdis/jit238. Epub 2013 May 28.

12.

In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.

Doern GV, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Richter SS.

Antimicrob Agents Chemother. 2012 Jun;56(6):3406-8. doi: 10.1128/AAC.00582-12. Epub 2012 Apr 9.

13.

L. Barth Reller, M.D.

Doern GV.

J Clin Microbiol. 2012 May;50(5):1510-2. doi: 10.1128/JCM.00313-12. Epub 2012 Feb 15. No abstract available.

14.

Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.

Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.

J Clin Microbiol. 2011 Dec;49(12):4203-7. doi: 10.1128/JCM.01152-11. Epub 2011 Oct 5.

15.

Why should the journal of clinical microbiology apologize for publishing a paper plagiarized from its archives?

Jacques Nsuami M, Besa N, Djamba YK, Sikabwe E, Nsa W, Doern GV.

J Clin Microbiol. 2011 Aug;49(8):3109-10; author reply 3112. doi: 10.1128/JCM.00881-11. No abstract available.

16.

Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, Biek D, Critchley IA, Diekema DJ, Doern GV.

Antimicrob Agents Chemother. 2011 Sep;55(9):4154-60. doi: 10.1128/AAC.00315-11. Epub 2011 Jun 27.

17.

Antibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure.

Desai H, Richter S, Doern G, Heilmann K, Dohrn C, Johnson A, Brauer A, Murphy T, Sethi S.

COPD. 2010 Oct;7(5):337-44. doi: 10.3109/15412555.2010.510162.

PMID:
20854048
18.

Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.

Van De Griend P, Herwaldt LA, Alvis B, DeMartino M, Heilmann K, Doern G, Winokur P, Vonstein DD, Diekema D.

Emerg Infect Dis. 2009 Oct;15(10):1582-9. doi: 10.3201/eid1510.080877.

19.

BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin.

Junkins AD, Lockhart SR, Heilmann KP, Dohrn CL, Von Stein DL, Winokur PL, Doern GV, Richter SS.

J Clin Microbiol. 2009 Sep;47(9):2879-82. doi: 10.1128/JCM.01109-09. Epub 2009 Jul 22.

20.

Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates.

Riedel S, Junkins A, Stamper PD, Cress G, Widness JA, Doern GV.

J Clin Microbiol. 2009 Jun;47(6):1645-9. doi: 10.1128/JCM.00302-09. Epub 2009 Apr 15.

21.

Patterns and density of early tracheal colonization in intensive care unit patients.

Durairaj L, Mohamad Z, Launspach JL, Ashare A, Choi JY, Rajagopal S, Doern GV, Zabner J.

J Crit Care. 2009 Mar;24(1):114-21. doi: 10.1016/j.jcrc.2008.10.009.

22.

Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.

Clin Infect Dis. 2009 Feb 1;48(3):e23-33. doi: 10.1086/595857.

PMID:
19115971
23.

Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.

Pichichero ME, Doern GV, Kuti JL, Nicolau DP.

Paediatr Drugs. 2008;10(6):391-7. doi: 10.2165/0148581-200810060-00006.

PMID:
18998749
24.

Lactobacillus delbrueckii as the cause of urinary tract infection.

Darbro BW, Petroelje BK, Doern GV.

J Clin Microbiol. 2009 Jan;47(1):275-7. doi: 10.1128/JCM.01630-08. Epub 2008 Nov 5.

25.

Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in children.

Fallon RM, Kuti JL, Doern GV, Girotto JE, Nicolau DP.

Paediatr Drugs. 2008;10(5):329-35.

PMID:
18754699
26.

Accuracy of phenotypic methods for identification of Streptococcus pneumoniae isolates included in surveillance programs.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.

J Clin Microbiol. 2008 Jul;46(7):2184-8. doi: 10.1128/JCM.00461-08. Epub 2008 May 21.

27.

Timing of specimen collection for blood cultures from febrile patients with bacteremia.

Riedel S, Bourbeau P, Swartz B, Brecher S, Carroll KC, Stamper PD, Dunne WM, McCardle T, Walk N, Fiebelkorn K, Sewell D, Richter SS, Beekmann S, Doern GV.

J Clin Microbiol. 2008 Apr;46(4):1381-5. doi: 10.1128/JCM.02033-07. Epub 2008 Feb 27. Erratum in: J Clin Microbiol. 2008 Jul;46(7):2475.

28.

Increasing telithromycin resistance among Streptococcus pyogenes in Europe.

Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV.

J Antimicrob Chemother. 2008 Mar;61(3):603-11. doi: 10.1093/jac/dkm525. Epub 2008 Jan 24.

PMID:
18218647
29.
30.

A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004.

Eagye KJ, Nicolau DP, Lockhart SR, Quinn JP, Doern GV, Gallagher G, Abramson MA.

Ann Clin Microbiol Antimicrob. 2007 Oct 1;6:11.

31.

Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV.

J Clin Microbiol. 2007 Oct;45(10):3352-9. Epub 2007 Aug 22.

32.

Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species.

Richter SS, Howard WJ, Weinstein MP, Bruckner DA, Hindler JF, Saubolle M, Doern GV.

J Clin Microbiol. 2007 Sep;45(9):2863-71. Epub 2007 Jul 25.

33.

Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae.

Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV.

Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):485-90.

PMID:
17551759
34.

Oral beta-lactams in the treatment of acute otitis media.

Block SL, Doern GV, Pfaller MA.

Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):19S-30S. Review.

PMID:
17349460
35.

parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones.

Sun HK, Du X, DeRyke CA, Doern GV, Nicolau DP.

Int J Antimicrob Agents. 2007 Feb;29(2):230-2. Epub 2007 Jan 3. No abstract available.

PMID:
17204405
36.
37.

Macrolide and ketolide resistance with Streptococcus pneumoniae.

Doern GV.

Med Clin North Am. 2006 Nov;90(6):1109-24. Review.

PMID:
17116439
38.

Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center.

Gray GC, Capuano AW, Setterquist SF, Erdman DD, Nobbs ND, Abed Y, Doern GV, Starks SE, Boivin G.

J Clin Virol. 2006 Dec;37(4):269-76. Epub 2006 Sep 27.

39.

Multidrug resistance in pediatric urinary tract infections.

Gaspari RJ, Dickson E, Karlowsky J, Doern G.

Microb Drug Resist. 2006 Summer;12(2):126-9.

PMID:
16922629
40.

Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates.

Riedel S, Siwek G, Beekmann SE, Richter SS, Raife T, Doern GV.

J Clin Microbiol. 2006 Jun;44(6):2262-4.

41.

Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study.

Beekmann SE, Diekema DJ, Heilmann KP, Richter SS, Doern GV.

Eur J Clin Microbiol Infect Dis. 2006 May;25(5):335-9.

PMID:
16612609
42.

Optimal antimicrobial therapy: the balance of potency and exposure.

Tillotson GS, Doern GV, Blondeau JM.

Expert Opin Investig Drugs. 2006 Apr;15(4):335-7.

PMID:
16548783
43.

Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.

Polgreen PM, Beekmann SE, Chen YY, Doern GV, Pfaller MA, Brueggemann AB, Herwaldt LA, Diekema DJ.

Infect Control Hosp Epidemiol. 2006 Mar;27(3):252-6. Epub 2006 Feb 28.

PMID:
16532412
44.

Antibiotic resistance trends in paediatric uropathogens.

Gaspari RJ, Dickson E, Karlowsky J, Doern G.

Int J Antimicrob Agents. 2005 Oct;26(4):267-71.

PMID:
16154724
45.

Antimicrobial resistance with Streptococcus pneumoniae in the United States.

Doern GV.

Semin Respir Crit Care Med. 2000;21(4):273-84.

PMID:
16088738
46.

Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.

Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV.

Clin Infect Dis. 2005 Sep 1;41(5):599-608.

PMID:
16080080
47.

Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures.

Beekmann SE, Diekema DJ, Doern GV.

Infect Control Hosp Epidemiol. 2005 Jun;26(6):559-66.

PMID:
16018432
48.

Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?

Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, Beekmann S.

Clin Infect Dis. 2005 Jul 15;41(2):139-48. Epub 2005 Jun 7.

PMID:
15983908
49.

Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.

Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, Richter SS, Doern GV.

Antimicrob Agents Chemother. 2005 Jun;49(6):2561-4.

50.

Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).

Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Doern GV, Diekema DJ.

J Clin Microbiol. 2005 May;43(5):2163-7.

Supplemental Content

Support Center